You have read all your free articles, to continue reading subscribe to read the rest of this content.
CEPI, the Coalition for Epidemic Preparedness Innovations, has launched a USD 3.5 billion plan to dramatically reduce or even eliminate the future risk of pandemics and epidemics. CEPI’s five-year plan sets out initiatives to build a future world that is better equipped to deal with these devasAlready a subscriber Login…
NextCell Pharma has announced that a patent application has been filed for the treatment of Sars-CoV-2 mediated severe pneumonia with ProTrans. NextCell increases the IP protection for the drug candidate ProTrans for the treatment of autoimmune diseases and inflammatory conditions. The latest patAlready a subscriber Login You have read all…
The first participants in a Phase II/III trial for AstraZeneca's new COVID-19 variant vaccine AZD2816 have been vaccinated to assess its safety and immunogenicity in both previously vaccinated and unvaccinated adults. The trial will recruit approximately 2,250 participants across UK, South AfricaAlready a subscriber Login You have read all your…
Researchers at Uppsala University and Uppsala University Hospital have developed a new method to measure levels of the medication hydroxychloroquine in patients with the rheumatic disease systemic lupus erythematosus (SLE). The analysis method may also be useful in other areas, such as in the treAlready a subscriber Login You have…
